帕金森病的基因疗法 使用中脑发育基因调节多巴胺基神经维护
Jintae Kim1, Mi-Yoon Chang2,3,4
1Channelopathy Research Center (CRC), Dongguk University College of Medicine, 32 Dongguk-ro, Goyang 10326, Republic of Korea.
International journal of molecular sciences
|November 27, 2024
概括
基因疗法为帕金森病 (PD) 治疗提供了一个有希望的新途径,有可能缓解症状并减缓进展. 研究正在探索神经变因子和基因编辑,以增强神经保护和疾病修饰.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕金森病 (PD) 是一种流行的神经退行性疾病,其特征是多巴胺神经元损失和多巴胺水平降低.
- 目前的治疗方法可以控制症状,但不能阻止PD的进展.
- 基因疗法是一个有希望的替代方案,有可能缓解症状和减少副作用.
研究的目的:
- 审查目前对帕金森病的基因治疗策略.
- 探索针对疾病修饰和神经保护的新型治疗方法.
主要方法:
- 对PD的基因疗法进行临床前和临床试验数据的审查.
- 对研究神经营养因子,发育因子 (Nurr1,Foxa2) 和下游途径调节的研究进行分析.
- 检查基因编辑和传递技术的进步.
主要成果:
- 腺相关病毒 (AAV) 介导的基因疗法 (例如,GAD,AADC) 在多巴胺替代的早期试验中显示出安全性和有效性.
- 针对神经元完整性 (例如,Nurr1,Foxa2) 和神经营养因子 (GDNF,BDNF,VEGF) 的疾病修饰策略显示出潜在的潜力.
- 针对自,线粒体功能和ER压力等途径显示出神经保护的前景.
结论:
- 基因治疗为帕金森病的症状缓解和疾病修饰提供了显著的潜力.
- 未来的研究应该专注于针对神经元和质细胞的协同方法,以及用于有效治疗PD的先进基因编辑技术.
关键词:
一个叫做Nurr1的.帕金森病是帕金森氏症的一种疾病.腺相关病毒的病毒.临床试验临床试验临床试验临床试验临床试验多巴胺能神经元的神经元基因治疗的基因疗法中脑发育基因 中脑发育基因临床前研究的临床前研究.更多相关视频
10:54Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression
Published on: February 10, 2017
9.3K
09:21Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
Published on: July 7, 2023
1.4K
相关概念视频
01:24Parkinson's Disease: Treatment
220
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
220
01:15Parkinson's Disease: Overview
482
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
482
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
00:59Gene Therapy
25.2K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.2K